Congress 2018 · 9.00 KEYNOTE: Global Microbiome Future Innovation, Partnerships, And Trends ·...

1microbiomeinvest.com | @MBCongress | #PitchYourMicrobes

Successfully Driving Business Partnerships And Showcasing Innovation In The Microbiome Field

Benefits of Attending:

Feature Speakers

Congress 201823, May 2018 | London, UK

David Berry General Partner

Isabelle De Cremoux CEO

Dr David Cook Chief Scientific Officer

John Hambour Director of Research Beyond Borders

Andrew Morgan DuPont Fellow & Chief Scientist

Cheryl Zimberlin Healthcare Associate

1 Learn which start ups are developing the most innovative microbiome therapeutic, diagnostic, and nutritional solutions and why you should invest in them now

2 Showcase your novel microbiome research or product on our ‘Pitch your Microbes’ Innovation Stage to gain investment and form collaborations with investors, and pharmaceutical and nutrition leaders of external innovation

3 Understand the challenges that leading microbiome biotechnology companies have experienced and overcome to allow you to develop a successful commercialisation plan

4 Determine how to navigate the regulatory pathway for microbiome therapeutics and diagnostics to form successful development plan for your microbiome product and achieve market launch

5 Forge new collaborations and business partnerships with leading nutrition and pharmaceutical companies and investors to secure funding and research partners through our meeting mojo platform


Who you WILL MEET:

Microbiome Invest 2018:

YOUR MICROBIOME NETWORKING WISHLISTWith close to 400 microbiome start-ups in 2017 compared to just 12 in 2013, the microbiome industry has experienced an exponential growth, with an increasing number of Biotech and Pharmaceutical companies seeking to capitalise on the translation of research into clinically and commercially viable medicine.

Over $616.9 million has been invested in microbiome companies in 2016, more than all venture investment in the microbiome space in 2011 to 2015 combined.

Following the success of the inaugural 2017 Microbiome Invest event, we are incredibly excited to present this exclusive one-day event, held in London on 23rd May 2018.

Connecting over 100 industry executives from early-stage microbiome start-ups, nutrition and pharmaceutical companies, venture capital and private equity investors, regulatory experts and ground-breaking solution providers.

In addition to the open networking available throughout the Forum’s networking breaks and receptions, our ‘MEETING MOJO’ platform allows you to create a bespoke meeting schedule, ensuring you connect with the industry stakeholders that are most important in building your business. Login details for the ‘MEETING MOJO’ platform will be sent to all registered attendees 4 weeks prior to the event to allow for connections to be made online and scheduling to occur. Productive networking guaranteed!

Meeting

MOJOEmerging Early Stage

Microbiome Companies

Strategic partnership and External Innovation Leads from Pharmaceutical and Nutrition Companies

Heathcare Investment Banks

Market Intelligence and Consultancy Providers

Established Microbiome Biotechnology Companies

Academics Looking to Commercialise

Venture Capital and Private Equity Investors

Intellectual Property Lawyers

Regulatory Experts


Speaker SPOTLIGHT



Artem Khlebinkov Director of Strategic Partnerships

Marie Drago Founder

Jim Weston Vice President and Head of Regulatory Affairs


John Hambour Director of Research Beyond Borders

Luc Sterkman CEO

Andrew Morgan DuPont Fellow & Chief Scientist

Derek Butler CEO

Oron Assaf Chief Business Officer

Adrian Ferrero CO-founder and CEO

Cheryl Zimberlin Healthcare Associate

Mike Romanos Chief Executive Officer


Pitch your MICR BES Selection Committee




Central to the Microbiome Invest is ‘Pitch Your Microbes’, a platform for 12 of the most exciting emerging companies in the microbiome space to pitch their innovative ideas to a room full of potential investors, collaborators and partners. Our esteemed selection committee will handpick these final 12 presenting companies from the list of all applicants.

TO APPLY, YOU SHOULD MEET ONE OF THE FOLLOWING ENTRY CRITERIA:

A recent spin-out from an academic institution looking for investment, partnerships and advice

An academic with a desire to develop and commercialise an innovative idea or piece of research

A biotech company at the pre-revenue or post-revenue stage, looking for investment, partnerships and advice

You do not need to be a registered company – you just need an innovative idea that could form the basis of a new product or service in the translational microbiome field!

TO APPLY, COMPLETE THE ONLINE APPLICATION FORM. DEADLINE: APRIL 2ND 2018.

Sponsorship OPPORTUNITESFar from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with the conference will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts.

CONTACT US: Ask us about the different ways you can get involved.

Contact our sponsorship team to find out more about each package by emailing [email protected] or by calling: +44 (0)20 3696 2925.

https://kisacoresearch.com/forms/pitch-your-microbes


Pitch your

MICR BES 2017Pitch your Microbes Winner 2017

Follow in the footsteps of our previous presenting companies at ‘Pitch Your Microbes’ Microbiome Invest 2017.

At Microbiome Invest 2017, Gallinée won the ‘Pitch Your Microbes’ competition, securing a year’s access to the Johnson & Johnson Innovation, JLINX Facility.

Marie Drogo Founder

Learn about the successes and challenges our ‘Pitch your Microbes’ 2017 finalists have experienced since the event during the ‘Where Are They Now?’ panel on this year’s agenda. “The Microbiome Invest Congress was such an amazing event for

Gallinée. Not only did I meet great people like S-Biomedic and AnimalBiome, we also got in contact with very interesting investors.

We just closed a deal with Unilever Ventures thanks to people we met at your event.”– Marie Drogo, Founder, Gallinée

2017

MICROBIOME INVEST

“My advice to start-ups is to focus on building your product early, test it, lead your vision with associated data and a pilot study, then create this around your real customers’ needs and feedback. Don’t focus all your efforts on investment too early, it is more important to demonstrate what your product will achieve.”

– Shannon Doyle, Founder, Smart Flora

https://www.youtube.com/watch%3Fv%3DT9D5wJmdUhw%0D


AGENDA 23, May 2018

8.30 Registration

8.50 Chairman’s Opening RemarksDavid Cook, EVP of R&D and Chief Scientific Officer, SeresTherapeutics

9.00 KEYNOTE: Global Microbiome Future Innovation, Partnerships, And Trends · Exciting recent investments and developments in the microbiome space

· Upcoming microbiome trigger points with technologies and disease focuses to watch in 2018 and beyond

Isabelle de Cremoux, CEO, Seventure Partners

9.20 How-To Prepare For The Progression And Challenges For Microbiome Products Of Different Modalities · Single strain bacteria-how much evidence of durable clinical efficacy do you need? Have you got a defendable IP?

· Consortia of bacteria-how robust are your manufacturing processes and are costs manageable?

· Microbiome-derived small molecules-what is the pathway for these?John Hambor, Director, Research Beyond Borders, Boehringer Ingelheim

9.40 Pitch Your Microbes 3 pre-selected emerging companies pitch their innovative ideas • Azitra Inc.• Ilya Pharma• OptiBiotix Ltd

10.20 Morning Networking Break And Meeting Mojo 10.25 Private Prescheduled Meeting10.40 Interval10.45 Private Prescheduled Meeting11.00 Interval11.05 Private Prescheduled Meeting

11.20 PANEL: The Journey Of A Microbiome Biotech · Important considerations when launching your company · How to ensure your IP is robust · The commercialisation process - working with regulators and industry advisors

· Challenges you will face along the way and lessons that can be learnt from other microbiome start-ups at different stages

Panellists:David Cook, EVP of R&D and Chief Scientific Officer, Seres TherapeuticsMike Romanos, CEO, MicrobioticaLuc Sterkman, CEO, Caelus Health B.V


AGENDA11.50 PANEL: In Conversation With:

Investors and pharmaceutical and nutrition companies discuss investment in the microbiome-what are investors and industry looking for in start-ups and academic collaborations in the microbiome space? · What evidence do investors/industry need from start ups for serious collaboration/investment talks to begin?

· How much data and IP should start-ups have to begin talks with investors and industry?

· Lessons learnt from previous investments-what start-ups should avoid to ensure success

· What is the future of microbiome diagnostics and therapeutics in healthcare?

Moderator: Cheryl Zimberlin, Healthcare Associate, Merck VenturesPanellists:David Berry, General Partner, Flagship VenturesIsabelle de Cremoux, CEO, Seventure PartnersAndrew Morgan, DuPont Fellow and Chief Scientist, DuPont Nutrition & HealthJohn Hambor, Director, Research Beyond Borders, Boehringer IngelheimArtem Khlebinkov, Director of Strategic Partnerships, Danone Nutrica Research

12.20 Pitch Your Microbes 3 pre-selected emerging companies pitch their innovative ideas• Perfood GmbH• Carbiotix AB• Lavivo

13.00 Networking Lunch And Meeting Mojo13.30 Private Prescheduled Meeting13.45 Interval13.50 Private Prescheduled Meeting14.05 Interval14.10 Private Prescheduled Meeting

14.25 Pitch Your Microbes 3 pre-selected emerging companies pitch their innovative ideas • ConsortiaTX• ImmuneBiotech AB• TargEDys SA

15.05 PANEL: Where Are They Now?Find out where the companies that presented at Microbiome Invest 2017 are now, lessons they have learnt during their experiences and plans for 2018 and beyondPanellists:Marie Drago, CEO, GallinéeDerek Butler, CEO and Co-founder, MyMicroZooAssaf Oron, CBO, MBcureAdrian Ferrero Fernandez, Co-founder & CEO, Biome Makers Inc.


AGENDA15.35 Regulation And Market Launch Of Microbiome Products

· It is known that the FDA prioritise safety over efficacy-the panel will discuss whether this is a commonly held view across regulatory bodies in Europe and how emerging companies should plan their research with this in mind

· How should start-ups plan trials, collect data and develop their microbiome products to ensure they pass regulatory hurdles and can successfully launch onto the market?

· MHRA, EMA and FDA-how are they looking at microbiome products and how can you make sure your product is successful?

· How will the regulatory bodies require you to standardise protocols and manufacturing processes to allow your microbiome product to enter the market.

Jim Weston, Head of Regulatory Affairs, Seres TherapeuticsA representative from the MHRA

16.00 Afternoon Networking Break And Meeting Mojo16.00 Private Prescheduled Meeting16.15 Interval16.20 Private Prescheduled Meeting16.35 Interval16.40 Private Prescheduled Meeting

“This was an excellent focussed event for the microbiome community whether biotech, pharma or investor to exchange views, speculate on the future and network.”

– Mike Romanos, Microbiotica

16.55 Pitch Your Microbes 3 pre-selected emerging companies pitch their innovative ideas • BioMe Oxford• Biomica Ltd.• Civet Biosciences

17.35 Microbiome Innovation in Animal HealthOliver Hardcastle, CEO, Anizome LLCThe potential for microbiome-based solutions in farm and companion animals.

18.00 Close of Conference


Series CALENDAR

Translating Academic Research into Clinically & Commercially Viable Therapeutics

FEBRUARY

20185 th-7th

San Diego, USAwww.humanmicrobiomecongress.com

Promoting Partnerships and Showcasing The Latest Innovation in The Microbiome Field

2018

MAY

23 rdLondon, UKwww.microbiomeinvest.com

Translating Academic Research into Clinically & Commercially Viable Therapeutics

2018

NOVEMBER

27th-29 th

www.microbiomecongress.com

Manipulating the Animal Microbiome

2018

MARCH

21th-22nd Kansas City, USAwww.animalmicrobiomecongressusa.com

NEW!

Manipulating the Animal Microbiome

JUNE

Paris, Franceanimalmicrobiomecongress.com2018

20 th-21st

The Microbiome as a New Frontier in the Etiology & Treatment of Cancer

2018

MAY

8 th-9 thBoston, USAwww.oncobiomecongressusa.com

MICROBI MECANCER

CONGRESS

NEW!

The Microbiome as a new Frontier; from Cosmetics to Dermatology. Boston, USA

Website TBC2018

MAY

30 th-31st

NEW!

“One of the most important things is to bring together people who have different expertise and all sorts of skills. There is no single person, no single institution which has all the knowledge that we need. Networking is absolutely crucial.” – Professor Dusko Ehrlich, Head of Research and Founder, GM, INRA

http://www.humanmicrobiomecongress.com

http://www.microbiomeinvest.com

http://www.microbiomecongress.com


Venue and PRICING

PASS TYPEEARLY BIRD

Book by 16th March 2018

STANDARD PRICING

Academics, Biotech Companies (Under 3 Years Old), & Investors £499 +VAT £599

Pharmaceutical, Nutrition & Biotech Companies (Over 3 Years Old) £1,399 +VAT £1,599

Service Providers (Including Investment Bankers, Lawyers, Consultants) £1,599 +VAT £1,899

Pricing Information

BOOK A TEAM TO SAVE MORE!Industry Rates Only: Team discounts cannot be combined with any other discount or offer

Book a Team of 3+ Save an Additional 10% Off

Book a Team of 5+ Save an Additional 15% Off

Microbiome Invest 2018 is taking place in London, United Kingdom. Venue details to be confirmed.

INTERESTED IN SPONSORSHIP?Please contact Mark Gavhure, Manager Commercial Partnerships +44(0) 203 696 2925 | [email protected]

Payment Terms: · Please note that a £49 GBP processing fee will apply to any invoices requested.

· All Prices are in GBP and are exclusive of VAT @ 20% · All Early Bird discount prices, including Group Discounts, must be paid in full by deadlines provided above.

· No discount offers can be combined with any other offer · Please view our Cancellation Policy · QUESTIONS? Please email [email protected]

Congress 2018 · 9.00 KEYNOTE: Global Microbiome Future Innovation, Partnerships, And Trends ·...

Documents

Transcript of Congress 2018 · 9.00 KEYNOTE: Global Microbiome Future Innovation, Partnerships, And Trends ·...